Correction to: Response to the Letter to the Editor by Koneswarakantha and Ménard
Ther Innov Regul Sci
.
2022 May;56(3):381.
doi: 10.1007/s43441-022-00399-9.
Authors
Silke Janitza
1
,
Madhurima Majumder
2
,
Franco Mendolia
3
,
Steffen Jeske
4
,
Hermann Kulmann
1
Affiliations
1
Bayer AG, Berlin, Germany.
2
Daiichi Sankyo, Inc., Basking Ridge, USA.
3
Bayer AG, Research & Development, Pharmaceuticals, Statistics and Data Insights, 42113, Wuppertal, Germany. franco.mendolia@bayer.com.
4
Chrestos Concept GmbH & Co. KG, Essen, Germany.
PMID:
35312989
DOI:
10.1007/s43441-022-00399-9
No abstract available
Publication types
Published Erratum